Effect of methotrexate on melanoma risk in older adults: Secondary analysis of a randomised controlled trial

Australas J Dermatol. 2022 Feb;63(1):114-115. doi: 10.1111/ajd.13727. Epub 2021 Sep 28.

Authors

Mabel K Yan^{1

2}, Rory Wolfe¹, Suzanne G Orchard¹, Michael E Ernst³, Victoria J Mar^{1

2}

Affiliations

¹ School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
² Victorian Melanoma Service, Alfred Health, Melbourne, Victoria,, Australia.
³ Department of Pharmacy Practice and Science, College of Pharmacy, Department of Family Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA,, USA.

No abstract available

Keywords: adverse effects; melanoma; methotrexate; risk; skin cancer.

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Dermatologic Agents / therapeutic use*
Humans
Melanoma / prevention & control*
Methotrexate / therapeutic use*
Randomized Controlled Trials as Topic
Risk Assessment
Skin Neoplasms / prevention & control*

Substances

Dermatologic Agents
Methotrexate

Associated data

ClinicalTrials.gov/NCT01038583

Grants and funding